Porcine reproductive and respiratory syndrome virus vaccines: Current status and strategies to a universal vaccine

Transboundary and Emerging Diseases

Volumn 61, Issue 2, 2014, Pages 109-120

  Hu, J ^a   Zhang, C ^a  

^a Virginia Polytechnic Institute and State University   (United States)

Author keywords

Broad protection; Porcine reproductive and respiratory syndrome; Porcine reproductive and respiratory syndrome virus; Universal vaccine; Vaccine

Indexed keywords

ARTERIVIRUS; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE; SUS;

LIVE VACCINE; VACCINE; VIRUS VACCINE;

ANIMAL; ARTERIVIRUS; BROAD PROTECTION; IMMUNOLOGY; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PRACTICE GUIDELINE; REVIEW; STANDARD; SWINE; UNIVERSAL VACCINE; VACCINATION; VIROLOGY;

BROAD PROTECTION; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; UNIVERSAL VACCINE; VACCINE;

ANIMALS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; PRACTICE GUIDELINES AS TOPIC; SWINE; VACCINATION; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 84897673522     PISSN: 18651674     EISSN: 18651682     Source Type: Journal    
DOI: 10.1111/tbed.12016     Document Type: Review

References (96)

1. Allen, T. M., and M. Altfeld, 2008: Crippling HIV one mutation at a time. J. Exp. Med. 205, 1003-1007.
2. Anderson, T. K., W. W. Laegreid, F. Cerutti, F. A. Osorio, E. A. Nelson, J. Christopher-Hennings, and T. L. Goldberg, 2012: Ranking viruses: measures of positional importance within networks define core viruses for rational polyvalent vaccine development. Bioinformatics 28, 1624-1632.
3. Bastos, R. G., O. A. Dellagostin, R. G. Barletta, A. R. Doster, E. Nelson, and F. A. Osorio, 2002: Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine 21, 21-29.
4. Bastos, R. G., O. A. Dellagostin, R. G. Barletta, A. R. Doster, E. Nelson, F. Zuckermann, and F. A. Osrio, 2004: Immune response of pigs inoculated with Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine 22, 467-474.
5. Benfield, D. A., E. Nelson, J. E. Collins, L. Harris, S. M. Goyal, D. Robison, W. T. Christianson, R. B. Morrison, D. Corcyca, and D. Chladek, 1992: Characterization of swine infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332). J. Vet. Diagn. Invest. 4, 127-133.
6. Bøtner, A., B. Strandbygaard, K. J. Sørensen, P. Have, K. G. Madsen, E. S. Madsen, and S. Alexandersen, 1997: Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine. Vet. Rec. 141, 497-499.
7. Cancel-Tirado, S. M., R. B. Evans, and K. J. Yoon, 2004: Monoclonal antibody analysis of porcine reproductive and respiratory syndrome virus epitopes associated with antibody-dependent enhancement neutralization of virus infection. Vet. Immunol. Immunopathol. 102, 249-262.
8. Cano, J. P., S. A. Dee, M. P. Murtaugh, and C. Pijoan, 2007a: Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate. Vaccine 25, 4382-4391.
9. Cano, J. P., S. A. Dee, C. Trincado, M. P. Murtaugh, and C. Pijoan, 2007b: Effect of a modified-live porcine reproductive and respiratory syndrome virus vaccine on the dynamics of homologous viral infection in pig populations. Am. J. Vet. Res. 68, 565-571.
10. Charerntantanakul, W., 2009: Adjuvants for porcine reproductive and respiratory syndrome virus vaccines. Vet. Immunol. Immunopathol. 129, 1-13.
11. Chen, X., and J. Liu, 2011: Generation and immunogenicity of transgenic potato expressing the GP5 protein of porcine reproductive and respiratory syndrome virus. J. Virol. Methods 173, 153-158.
12. Chia, M. Y., S. H. Hsiao, H. T. Chan, Y. Y. Do, P. L. Huang, H. W. Chang, Y. C. Tsai, C. M. Lin, V. F. Pang, and C. R. Jeng, 2010: Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant. Vet. Immunol. Immunopathol. 135, 234-242.
13. Chia, M. Y., S. H. Hsiao, H. T. Chan, Y. Y. Do, P. L. Huang, H. W. Chang, Y. C. Tsai, C. M. Lin, V. F. Pang, and C. R. Jeng, 2011: Evaluation of the immunogenicity of a transgenic tobacco plant expressing the recombinant fusion proteins of GP5 of porcine reproductive and respiratory syndrome virus and B subunit of Escherichia coli heat-labile enterotoxin in pigs. Vet. Immunol. Immunopathol. 140, 215-225.
14. Collins, J. E., D. A. Benfield, W. T. Christianson, L. Harris, J. S. Hennings, D. P. Shaw, S. M. Goyal, S. McCullough, R. B. Morrison, H. S. Joo, D. Gorcyca, and D. Chladek, 1992: Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs. J. Vet. Diagn. Invest. 4, 117-126.
15. Daniell, H., N. D. Singh, H. Mason, and S. J. Streatfield, 2009: Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci. 14, 669-679.
16. Das, P. B., P. X. Dinh, I. H. Ansari, M. de Lima, F. A. Osorio, and A. K. Pattnaik, 2010: The minor envelope glycoproteins GP2a and GP4 of porcine reproductive and respiratory syndrome virus interact with the receptor CD163. J. Virol. 84, 1731-1740.
17. Dea, S., C. A. Gagnon, H. Mardassi, and D. Rogan, 2000: Current knowledge on the structural proteins of porcine reproductive and respiratory (PRRS) virus: comparison of the North American and European isolates. Arch. Virol. 145, 659-688.
18. Delputte, P. L., N. Vanderheijden, H. J. Nauwynck, and M. B. Pensaert, 2002: Involvement of the matrix protein in attachment of porcine reproductive and respiratory syndrome virus to a heparinlike receptor on porcine alveolar macrophages. J. Virol. 76, 4312-4320.
19. Diaz, I., L. Darwich, G. Pappaterra, J. Pujols, and E. Mateu, 2006: Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs. Virology 351, 249-259.
20. Diaz, I., J. Pujols, L. Ganges, M. Gimeno, L. Darwich, M. Domingo, and E. Mateu, 2009: In silico prediction and ex vivo evaluation of potential T-cell epitopes in glycoproteins 4 and 5 and nucleocapsid protein of genotype-I (European) of porcine reproductive and respiratory syndrome virus. Vaccine 27, 5603-5611.
21. Domingo, E., J. Diez, M. A. Martinez, J. Hernandez, A. Holguin, B. Borrego, and M. G. Mateu, 1993: New observation on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection. J. Gen. Virol. 74, 2039-2045.
22. Domingo, E., C. Escarmis, N. Sevilla, A. Moya, S. F. Elena, J. Quer, I. S. Novella, and J. J. Holland, 1996: Basic concepts in RNA virus evolution. FASEB J. 10, 859-864.
23. Ellingson, J. S., Y. Wang, S. Layton, J. Ciacci-Zanella, M. B. Roof, and K. S. Faaberg, 2010: Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras. Vaccine 28, 2679-2686.
24. Fang, Y., and E. J. Snijderb, 2010: The PRRSV replicase: exploring the multifunctionality of an intriguing set of nonstructural proteins. Virus Res. 154, 61-76.
25. Fang, L., Y. Jiang, S. Xiao, C. Niu, H. Zhang, and H. Chen, 2006: Enhanced immunogenicity of modified GP5 of porcine reproductive and respiratory syndrome virus. Virus Genes 32, 5-11.
26. Forsberg, R., T. Storgaard, H. S. Nielsen, M. B. Oleksiewicz, P. Cordioli, G. Sala, J. Hein, and A. Bøtner, 2002: The genetic diversity of European type PRRSV is similar to that of North American type but is geographically skewed with Europe. Virology 299, 38-47.
27. Goldberg, T. L., J. F. Lowe, S. M. Milbern, and L. D. Firkins, 2003: Quasispecies variation of porcine reproductive and respiratory syndrome virus during natural infection. Virology 317, 197-207.
28. Hill, H., 1990: Overview and history of mystery swine disease (swine infertility/respiratory syndrome). In: Proceedings of the Mystery Swine Disease Committee Meeting, pp. 29-31. Denver, CO. Livestock Conservation Institute, Madison, WI.
29. Hu, J., Y. Ni, B. A. Dryman, X. J. Meng, and C. Zhang, 2010: Purification of porcine reproductive and respiratory virus from cell culture using ultrafiltration and heparin affinity chromatography. J. Chromatogr. A 1217, 3489-3493.
30. Hu, J., Y. Ni, B. A. Dryman, X. J. Meng, and C. Zhang, 2012: Immunogenicity study of plant-made oral subunit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV). Vaccine 30, 2068-2074.
31. Jiang, P., W. Jiang, Y. Li, S. Wu, and J. Xu, 2004: Humoral immune response induced by oral administration S. typhimurium containing a DNA vaccine against porcine reproductive and respiratory syndrome virus. Vet. Immunol. Immunopathol. 102, 321-328.
32. Jiang, W., P. Jiang, Y. Li, J. Tang, X. Wang, and S. Ma, 2006a: Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice. Vet. Immunol. Immunopathol. 113, 169-180.
33. Jiang, Y., S. Xiao, L. Fang, X. Yu, Y. Song, C. Niu, and H. Chen, 2006b: DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity. Vaccine 24, 2869-2879.
34. Jiang, W., P. Jiang, Y. Li, X. Wang, and Y. Du, 2007: Analysis of immunogenicity of minor envelope protein GP3 of porcine reproductive and respiratory syndrome virus in mice. Virus Genes 35, 695-704.
35. Jiang, W., P. Jiang, X. Wang, Y. Li, Y. Du, and X. Wang, 2008: Enhanced immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and/or GP4 of PRRS virus. Virus Res. 136, 50-57.
36. Johnson, C. R., T. F. Griggs, J. Gnanandarajah, and M. P. Murtaugh, 2011: Novel structural protein in porcine reproductive and respiratory syndrome virus encoded by an alternative ORF5 present in all arteriviruses. J. Gen. Virol. 92, 1107-1116.
37. Keffaber, K., 1989: Reproductive failure of unknown etiology. Am. Assoc. Swine Pract. Newslett. 1, 2-10.
38. Key, K. F., D. K. Guenette, K. J. Yoon, P. G. Halbur, T. E. Toth, and X. J. Meng, 2003: Development of a heteroduplex mobility assay to identify field isolates of porcine reproductive and respiratory syndrome virus with nucleotide sequences closely related to those of modified live-attenuated vaccines. J. Clin. Microbiol. 41, 2433-2439.
39. Kim, H., H. K. Kim, J. H. Jung, Y. J. Choi, J. Kim, C. G. Um, S. B. Hyun, S. Shin, B. Lee, G. Jang, B. K. Kang, H. J. Moon, and D. S. Song, 2011: The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods. Virol. J. 8, 323-334.
40. Kimman, T. G., L. A. Cornelissen, R. J. Moormann, J. M. J. Rebel, and N. Stockhofe-Zurwieden, 2009: Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology. Vaccine, 27, 3704-3718.
41. Korber, B. T., N. L. Letvin, and B. F. Haynes, 2009: T-cell vaccine strategies for human immunodeficiency virus, the virus with thousand faces. J. Virol. 83, 8300-8314.
42. Labarque, G., S. Van Gucht, K. V. Reeth, H. Nauwynck, and M. Pensaert, 2003: Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccines. Vet. Microbiol. 95, 187-197.
43. Labarque, G., K. V. Reeth, H. Nauwynck, C. Drexler, S. Van Gucht, and M. Pensaert, 2004: Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy. Vaccine 22, 4183-4190.
44. Lee, C., and D. Yoo, 2006: The small envelope protein of porcine reproductive and respiratory syndrome virus possesses ion channel protein-like properties. Virology 355, 30-43.
45. Letourneau, S., E. J. Im, T. Mashishi, C. Brereton, A. Bridgeman, H. Yang, L. Dorrell, T. Dong, B. Korber, A. J. McMichael, and T. Hanke, 2007: Design and pre-clinical evaluation of a universal HIV-1 vaccine. PLoS ONE 2, e984.
46. Li, B., S. Xiao, Y. Wang, S. Xu, Y. Jiang, H. Chen, and L. Fang, 2009: Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by synthetic ORF5 gene. Vaccine 27, 1957-1963.
47. de Lima, M., A. K. Pattnaik, E. F. Flores, and F. A. Osorio, 2006: Serologic marker candidates identified among B-cell linear epitopes of Nsp2 and structural proteins of a North American strain of porcine reproductive and respiratory syndrome virus. Virology 353, 410-421.
48. Linhares, D., M. Torremorell, J. P. Cano, and S. A. Dee, 2012: Effect of modified live porcine reproductive and respiratory syndrome (PRRS) vaccine on the shedding of wild-type virus from an endemically infected population of growing pigs. Vaccine 30, 407-413.
49. Livingston, B. D., M. Newman, C. Crimi, D. McKinney, R. Chesnut, and A. Sette, 2001: Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine 19, 4652-4660.
50. Lopez, O. J., and F. A. Osorio, 2004: Role of neutralizing antibodies in PRRSV protective immunity. Vet. Immunol. Immunopathol. 102, 155-163.
51. Loula, T., 1991: Mystery pig disease. Agri-practice 12, 23-24.
52. Madsen, K. G., C. M. Hansen, E. S. Madsen, B. Strandbygaard, A. Bøtner, and K. J. Sørensen, 1998: Sequence analysis of porcine reproductive and respiratory syndrome virus of the American type collected from Danish swine herds. Arch. Virol. 143, 1683-1690.
53. Mardassi, H., B. Massie, and S. Dea, 1996: Intracellular synthesis, processing, and transport of protein encoded by ORFs 5-7 of porcine reproductive and respiratory syndrome virus. Virology 221, 98-112.
54. Martelli, P., P. Cordioli, L. G. Alborali, S. Gozio, E. De Angelis, L. Ferrari, G. Lombardi, and P. Borghetti, 2007: Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain. Vaccine 25, 3400-3408.
55. Martelli, P., S. Gozio, L. Ferrari, S. Rosina, E. De Angelis, C. Quintavalla, E. Bottarell, and P. Borghetti, 2009: Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: clinical protection and cell-mediated immunity. Vaccine 27, 3788-3799.
56. Mateu, E., and I. Diaz, 2008: The challenge of PRRS immunology. Vet. J. 177, 345-351.
57. Meng, X. J., 2000: Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development. Vet. Microbiol., 74, 309-329.
58. Mengeling, W. L., K. M. Lager, A. C. Vorwald, and D. F. Clouser, 2003: Comparative safety and efficacy of attenuated single-strain and multi-strain vaccines for porcine reproductive and respiratory syndrome. Vet. Microbiol. 93, 25-38.
59. Murtaugh, M. P., Z. Xiao, and F. Zuckermann, 2002: Immunological responses of swine to porcine reproductive and respiratory syndrome virus infection. Viral Immunol. 15, 533-547.
60. Neumann, E. J., J. B. Kliebenstein, C. D. Johson, J. W. Mabry, E. J. Bush, A. H. Seitzinger, A. L. Green, and J. J. Zimmerman, 2005: Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. J. Am. Vet. Med. Assoc. 227, 385-392.
61. Nochi, T., H. Takagi, Y. Yuki, L. Yang, T. Masumura, M. Mejima, U. Nakanishi, A. Matsumura, A. Uozumi, H. Takachika, K. Tanka, F. Takaiwa, and H. Kiyono, 2007: Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc. Natl. Acad. Sci. U.S.A. 104, 10986-10991.
62. Nodelijk, G., M. C. M. de Jong, L. A. M. G. van Leengoed, G. Wensvoort, J. M. A. Pol, P. J. G. M. Steverink, and J. H. M. Verheijden, 2001: A quantitative assessment of the effectiveness of PRRSV vaccination in pigs under experimental conditions. Vaccine 19, 3636-3644.
63. Okuda, Y., M. Kuroda, M. Ono, S. Chikata, and I. Shibata, 2008: Efficacy of vaccination with porcine reproductive and respiratory syndrome virus following challenges with field isolates in Japan. J. Vet. Med. Sci. 70, 1017-1025.
64. Oleksiewicz, M. B., A. Bøtner, K. G. Madsen, and T. Storgaard, 1998: Sensitive detection and typing of porcine reproductive and respiratory syndrome virus by RT-PCR amplification of whole viral genes. Vet. Microbiol. 64, 7-22.
65. Opriessnig, T., P. G. Halbur, K. J. Yoon, R. M. Pogranichniy, K. M. Harmon, R. Evans, K. F. Key, F. J. Pallares, P. Thomas, and X. J. Meng, 2002: Comparison of molecular and biological characteristics of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Ingelvac PRRS MLV), the parent strain of the vaccine (ATCC VR2332), ATCC VR2385, and two recent field isolates of PRRSV. J. Virol. 76, 11837-11844.
66. Ostrowski, M., J. A. Galeota, A. M. Jar, K. B. Platt, F. A. Osorio, and O. J. Lopez, 2002: Identification of neutralizing and non-neutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J. Virol. 76, 4241-4250.
67. Pesch, S., C. Meyer, and V. F. Ohlinger, 2005: New insights into the genetic diversity of European porcine reproductive and respiratory syndrome virus (PRRSV). Vet. Microbiol. 107, 31-48.
68. Pirzadeh, B., and S. Dea, 1998: Immune response in pigs vaccinated with plasmid DNA encoding ORF5 of porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 79, 989-999.
69. Plagemann, P. G. W., 2004: The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus. Vet. Immunol. Immunopathol. 102, 263-275.
70. Plana Duran, J., I. Climent, J. Sarraseca, A. Urniza, E. Cortes, and J. L. Casal, 1997: Baculovirus expression of proteins of porcine reproductive and respiratory syndrome virus strain Olot/91. Involvement of ORF3 and ORF5 proteins in protection. Virus Genes 14, 19-29.
71. Pogrebnyak, N., M. Golovkin, V. Andrianov, S. Spitsin, Y. Smirnov, R. Egolf, and H. Koprowski, 2005: Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine. Proc. Natl. Acad. Sci. U.S.A. 102, 9062-9067.
72. Pol, J. M. A., F. Wagennaar, and J. E. G. Reus, 1997: Comparative morphogenesis of three PRRS virus strains. Vet. Microbiol. 55, 203-208.
73. Qiu, H. J., Z. J. Tian, G. Z. Tong, Y. J. Zhou, J. Q. Ni, Y. Z. Luo, and X. H. Cai, 2005: Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets. Vet. Immunol. Immunopathol. 106, 309-319.
74. Rolland, M., D. C. Nickle, and J. I. Mullins, 2007: HIV-1 group M conserved elements vaccine. PLoS Pathog. 3, e157.
75. Sabine, N., T. Deroo, and X. Saelens, 1999: A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med. 5, 1157-1163.
76. Scortti, M., C. Prieto, E. Alvarez, I. Simarro, and J. M. Castro, 2007: Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV. Vet. Rec. 161, 809-813.
77. Shen, G., N. Jin, M. Ma, K. Jin, M. Zheng, and H. Lu, 2007: Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18. Vaccine 25, 4193-4202.
78. Snijder, E. J., and J. J. Meulenberg, 1998: The molecular biology of arteriviruses. J. Gen.Virol. 79, 961-979.
79. Storgaard, T., M. B. Oleksiewicz, and A. Bøtner, 1999: Examination of the selective pressures on a live PRRS vaccine virus. Arch. Virol. 144, 2389-23401.
80. Terpstra, C., G. Wensvoorst, and J. M. A. Pol, 1991: Experimental reproduction of porcine epidemic abortion and respiratory syndrome (mystery swine disease) by infection with Lelystad virus: Koch's postulates fulfilled. Vet. Q. 13, 131-136.
81. Tian, Z. J., T. Q. An, Y. J. Zhou, J. M. Peng, S. P. Hu, T. C. Wei, Y. F. Jiang, Y. Xiao, and G. Z. Tong, 2009: An attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) protects piglets against HP-PRRS. Vet. Microbiol. 38, 34-40.
82. Van Breedam, W., H. Van Gorp, J. Q. Zhang, P. R. Crocker, P. L. Delputte, and H. J. Nauwynck, 2010a: The M/GP5 glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner. PLoS Pathog. 6, e1000730.
83. Van Breedam, W., P. L. Delputte, H. Van Gorp, G. Misinzo, N. Vanderheijden, X. Duan, and H. J. Nauwynck, 2010b: Porcine reproductive and respiratory syndrome virus entry into the porcine macrophage. J. Gen. Virol. 91, 1659-1667.
84. Van Vugt, J. J. F. A., T. Storgaard, M. B. Oleksiewicz, and A. Botner, 2001: High frequency RNA recombination in porcine reproductive and respiratory syndrome virus occurs preferentially between parental sequences with high similarity. J. Gen. Virol. 82, 2615-2620.
85. Vashisht, K., T. L. Goldberg, R. J. Husmann, W. S. Husmann, and F. A. Zuckermann, 2008: Identification of immunodominant T-cell epitopes present in glycoprotein 5 of the North American genotype of porcine reproductive and respiratory syndrome recombinant virus. Vaccine 26, 4747-4753.
86. Verheije, M. H., M. V. Kroese, I. F. A. van der Linder, E. A. de Boer-Luijtze, P. A. van Rijin, J. M. A. Pol, J. J. M. Meulenberg, and P. J. G. M. Steverink, 2003: Safety and protective efficacy of porcine reproductive and respiratory syndrome recombinant virus vaccines in young pigs. Vaccine 21, 2556-2563.
87. Wan Welch, S. K., R. Jolie, D. S. Pearce, W. D. Koertje, E. Fuog, S. L. Shields, D. Yoo, and J. G. Calvert, 2004: Construction and evaluation of genetically engineered replication-defective porcine reproductive and respiratory syndrome virus vaccine candidates. Vet. Immunol. Immunopathol. 102, 277-290.
88. Wang, Y., Y. Liang, J. Han, K. M. Burkhart, E. M. Vaughn, M. B. Roof, and K. S. Faaberg, 2008: Attenuation of porcine reproductive and respiratory syndrome virus strain MN184 using chimeric construction with vaccine sequence. Virology 371, 418-429.
89. Wensvoort, G., C. Terpstra, J. M. A. Pol, E. A. Lask, M. Bloemraad, E. P. de Kluyver, C. Kragten, L. van Buiten, A. A. den Besten, and F. F. Wagenaar, 1991: Mystery swine disease in the Netherlands: the isolation of Lelystad virus. Vet. Q. 13, 121-130.
90. Wissink, E. H. J., M. V. Kroese, H. A. R. van Wijk, F. A. M. Rijsewijk, J. J. M. Meulenberg, and P. J. M. Rottier, 2005: Envelope protein requirements for the assembly of infectious virions of porcine reproductive and respiratory syndrome virus. J. Virol. 79, 12495-12506.
91. Yang, O. O., 2008: Retracing our STEP towards a successful CTL-based HIV-1 vaccine. Vaccine 26, 3138-3141.
92. Yoon, K. J., L. L. Wu, J. J. Zimmerman, H. T. Hill, and K. B. Platt, 1996: Antibody-dependent enhancement (ADE) of porcine reproductive and respiratory syndrome virus (PRRSV) infection in pigs. Viral Immunol. 9, 51-63.
93. Yuan, S., C. J. Nelsen, M. P. Murtaugh, B. J. Schmitt, and K. S. Faaberg, 1999: Recombination between North American strains of porcine reproductive and respiratory syndrome virus. Virus Res. 61, 87-98.
94. Zheng, Q., D. Chen, P. Li, Z. Bi, B. Zhou, and P. Chen, 2007: Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus Ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV). Virus Genes 35, 585-595.
95. Zhou, J. X., J. D. Xue, J. D. Xu, J. B. Zhang, Y. Liu, N. Jiang, Y. L. Li, and R. L. Hu, 2010: Immune responses in pigs induced by recombinant canine adenovirus 2 expressing the glycoprotein 5 of porcine reproductive and respiratory syndrome virus. Vet. Res. Commun. 34, 371-380.
96. Zuckermann, F. A., E. A. Garcia, I. D. Luque, J. Christopher-Hennings, A. Doster, M. Brito, and F. Osorio, 2007: Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Vet. Microbiol. 123, 69-85.